Refuge Biotechnologies' Series B Round

Refuge Biotechnologies raised a round of funding on May 02, 2018.

Refuge Biotechnologies is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decis…

Articles about Refuge Biotechnologies' Series B Round: